Clinical Trial Update: Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 trial comparing bevacizumab added to endocrine therapy versus endocrine therapy alone as first-line treatment in postmenopausal women with breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-07-10